Viroloxía e Patoxénese ‘VIP’
Publicacións (262) Publicacións nas que participase algún/ha investigador/a
2024
-
Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain
AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314
-
Changes in bodyweight after initiating antiretroviral therapy close to HIV-1 seroconversion: an international cohort collaboration
The Lancet HIV
-
Clinical usefulness of serum angiotensin converting enzyme in silicosis
Pulmonology, Vol. 30, Núm. 4, pp. 370-377
-
Cross-sectional analysis of a cohort of people over 65 years of age living with HIV
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 6, pp. 317-320
-
Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in HIV late presenters
International Journal of Antimicrobial Agents, Vol. 63, Núm. 1
-
Elevated plasma levels of IP-10 and MIG are early predictors of loss of control among elite HIV controllers
Frontiers in Immunology, Vol. 15
-
Laboratory Report of HIV-1 Low-Level Viremia
Open Forum Infectious Diseases
2023
-
1586 - CARACTERÍSTICAS DE LA INFECCIÓN POR SARS-COV-2 EN PACIENTES EN TRATAMIENTO CON ANTICUERPOS MONOCLONALES ANTI-CD20 DESDE EL INICIO DE LA PANDEMIA
Revista Clínica Española, Vol. 223, Núm. Supl 2, pp. S426-S427
-
1706 - ¿COMO HEMOS MANEJADO LA INFECCIÓN POR SARS-COV-2 EN PACIENTES DIAGNOSTICADOS DE NEOPLASIAS HEMATOLÓGICAS EN TRATAMIENTO CON RITUXIMAB?
Revista Clínica Española, Vol. 223, Núm. Supl 2, pp. S428-S429
-
7 - IMPACTO DE LA PANDEMIA POR COVID-19 EN LA INCIDENCIA DE COLONIZACIÓN-INFECCIÓN POR STAPHYLOCOCCUS AUREUS RESISTENTE A METICILINA.
Revista Clínica Española, Vol. 223, Núm. Supl 2, pp. S806-S807
-
A Randomized Trial of Dolutegravir Plus Darunavir/ Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes
Open Forum Infectious Diseases, Vol. 10, Núm. 11
-
BACTERIEMIA EN PERSONAS QUE VIVEN CON VIH A LO LARGO DE 34 AÑOS
Revista Clínica Española, Vol. 223, Núm. Supl 2, pp. S706-S707
-
Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study
Frontiers in Cellular and Infection Microbiology, Vol. 13
-
Evolution and long‑term respiratory sequelae after severe COVID-19 pneumonia: nitric oxide diffusion measurement value
Respiratory Research, Vol. 24, Núm. 1
-
High Levels of IL-1β, TNF-α and MIP-1α One Month after the Onset of the Acute SARS-CoV-2 Infection, Predictors of Post COVID-19 in Hospitalized Patients
Microorganisms, Vol. 11, Núm. 10
-
IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors
Frontiers in Immunology, Vol. 14
-
Impact of Methylprednisolone Pulse on the Mortality of Patients With Acute Respiratory Distress Syndrome Secondary to COVID-19
Infectious Diseases in Clinical Practice, Vol. 31, Núm. 6
-
Interleukin 18 (IL-18) and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1
Journal of Infectious Diseases
-
Meningococcal carriage in men who have sex with men presenting at a sexual health unit in Spain
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 42, Núm. 3, pp. 287-296
-
Plasma Human Immunodeficiency Virus 1 RNA and CD4+T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes with Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study
Clinical Infectious Diseases